{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:50:20Z","timestamp":1761889820108,"version":"build-2065373602"},"reference-count":33,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,11,25]],"date-time":"2009-11-25T00:00:00Z","timestamp":1259107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:p>\n                    <jats:bold>Aim:<\/jats:bold>\n                    The benefit of direct, as opposed to calculated, low density lipoprotein \u2010cholesterol (LDL\u2010C) measurement remains unclear. This study compared the biological variability of direct LDL in patients with type 2 diabetes (T2DM) on equivalent doses of the short half\u2010life statin, simvastatin or the longer half\u2010life statin, atorvastatin.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    A cross\u2010over study of biological variation of lipids in 26 patients with T2DM taking either simvastatin 40 mg (n = 10) or atorvastatin 10 mg. After 3 months on one statin, fasting lipids were measured on 10 occasions over a 5\u2010week period. The same procedure was then followed on the other statin. The variability of LDL\u2010C was established using a Beckman direct assay.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    As a group, mean LDL was no different between statins (mean \u00b1 s.d.) (1.69 \u00b1 0.60 mmol\/l simvastatin vs. 1.67 \u00b1 0.60 mmol\/l atorvastatin, p = 0.19). However, in all patients, the intraindividual biological variability of LDL while taking simvastatin was markedly higher than with atorvastatin (average s.d. = 0.17 mmol \/l simvastatin vs. 0.01 mmol\/l, p &lt; 0.0001). Friedewald calculated LDL variability was no different between statins (average s.d. = 0.34 mmol \/l simvastatin vs. 0.21 mmol\/l atorvastatin, p = 0.19).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    In contrast to calculated values, direct measurement revealed LDL to be much more stable (the s.d. being an order of magnitude) in T2DM patients taking atorvastatin rather than simvastatin. This means LDL targets can be consistently met with less lipid monitoring using atorvastatin rather than simvastatin. Direct LDL measurement may therefore have a particular role in monitoring patients on statin treatment.\n                  <\/jats:p>","DOI":"10.1111\/j.1463-1326.2009.01190.x","type":"journal-article","created":{"date-parts":[[2009,11,25]],"date-time":"2009-11-25T16:17:05Z","timestamp":1259165825000},"page":"540-544","source":"Crossref","is-referenced-by-count":8,"title":["Low density lipoprotein\u2010cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement?"],"prefix":"10.1111","volume":"12","author":[{"given":"T.","family":"Sathyapalan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"Atkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. S.","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,20]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.106.25.3143"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13636-7"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.19.2437"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-2465"},{"key":"e_1_2_7_6_2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo\u2010controlled trial","volume":"364","author":"Colhoun HM","journal-title":"Lancet"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.4.614"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.089763"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.99.2.185"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2008.02519.x"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.8.1081"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/48.2.236"},{"key":"e_1_2_7_14_2","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/clinchem\/42.5.732","article-title":"Variability in cholesterol measurements: comparison of calculated and direct LDL cholesterol determinations","volume":"42","author":"Schectman G","year":"1996","journal-title":"Clin Chem"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7404.1423"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020557"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.1.278"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/10408368909106595"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2007.S68"},{"volume-title":"Lipid Modification: Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease","year":"2008","author":"NICE","key":"e_1_2_7_20_2"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-9-200805060-00005"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.17.1836"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2005.06.035"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/1047-2797(92)90033-M"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90597-0"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00159-2"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.19.2437"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.4065\/83.12.1316"},{"key":"e_1_2_7_29_2","doi-asserted-by":"crossref","unstructured":"FoodyJM JoyceAT RudolphAE LiuLZ BennerJS.Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States. Clin Ther2008;30:195\u2013205.","DOI":"10.1016\/j.clinthera.2008.01.003"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X61866"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.06.034"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.11.1307"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040583"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050461"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1326.2009.01190.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/j.1463-1326.2009.01190.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:54:03Z","timestamp":1761882843000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/j.1463-1326.2009.01190.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,20]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1463-1326.2009.01190.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1463-1326.2009.01190.x","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"type":"print","value":"1462-8902"},{"type":"electronic","value":"1463-1326"}],"subject":[],"published":{"date-parts":[[2010,4,20]]}}}